Barclays PLC Heron Therapeutics, Inc. Call Options Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 10, 2020	BUY	$17.42 - $26.61 $19,162 - $29,271	1,100 Added 550.0%	1,300 $31,000
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $148,876 - $194,649	-9,100 Reduced 97.85%	200 $4,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $863,576 - $1.25 Million	-39,200 Reduced 80.82%	9,300 $241,000
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $1.3 Million - $1.77 Million	43,400 Added 850.98%	48,500 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $118,800 - $189,000	4,500 Added 750.0%	5,100 $198,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $51,604 - $80,640	-2,800 Reduced 82.35%	600 $17,000
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $28,120 - $35,815	1,900 Added 126.67%	3,400 $62,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $21,975 - $25,275	1,500	1,500 $24,000

178

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $186M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.